Downregulated Circular RNA hsa_circ_0000291 Suppresses Migration And Proliferation Of Gastric Cancer Via Targeting The miR-183/ITGB1 Axis

References

• Hartgrink HH, Jansen EP, van Grieken NC, van de Velde CJ. Gastric cancer. Lancet. 2009;374(9688):477–490. doi:10.1016/S0140-6736(09)60617-619625077
   PubMed Web of Science ®Google Scholar
• Yagi K, Nozawa Y, Endou S, Nakamura A. Diagnosis of early gastric cancer by magnifying endoscopy with NBI from viewpoint of histological imaging: mucosal patterning in terms of white zone visibility and its relationship to histology. Diagn Ther Endosc. 2012;2012:954809. doi:10.1155/2012/95480923258955
   PubMedGoogle Scholar
• Patt YZ, Hassan MM, Lozano RD, et al. Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clin Cancer Res. 2001;7(11):3375–3380.11705850
   PubMed Web of Science ®Google Scholar
• Martin R, Jarnagin W. Intrahepatic cholangiocarcinoma. Current management. Minerva Chir. 2003;58(4):469–478.14603159
   PubMedGoogle Scholar
• Prensner JR, Chinnaiyan AM. The emergence of lncRNAs in cancer biology. Cancer Discov. 2011;1(5):391–407. doi:10.1158/2159-8290.CD-11-020922096659
   PubMed Web of Science ®Google Scholar
• Shi X, Sun M, Liu H, Yao Y, Song Y. Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339(2):159–166. doi:10.1016/j.canlet.2013.06.01323791884
   PubMed Web of Science ®Google Scholar
• Dang Y, Ouyang X, Zhang F, et al. Circular RNAs expression profiles in human gastric cancer. Sci Rep. 2017;7(1):9060. doi:10.1038/s41598-017-09076-628831102
   PubMedGoogle Scholar
• Zhang J, Liu H, Hou L, et al. Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression. Mol Cancer. 2017;16(1):151. doi:10.1186/s12943-017-0719-328893265
   PubMed Web of Science ®Google Scholar
• Huang M, He YR, Liang LC, Huang Q, Zhu ZQ. Circular RNA hsa_circ_0000745 may serve as a diagnostic marker for gastric cancer. World J Gastroenterol. 2017;23(34):6330–6338. doi:10.3748/wjg.v23.i34.633028974900
   PubMed Web of Science ®Google Scholar
• Qu S, Zhong Y, Shang R, et al. The emerging landscape of circular RNA in life processes. RNA Biol. 2017;14(8):992–999. doi:10.1080/15476286.2016.122047327617908
   PubMed Web of Science ®Google Scholar
• Qu S, Yang X, Li X, et al. Circular RNA: a new star of noncoding RNAs. Cancer Lett. 2015;365(2):141–148. doi:10.1016/j.canlet.2015.06.00326052092
   PubMed Web of Science ®Google Scholar
• Wang L, Tong X, Zhou Z, et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer. Mol Cancer. 2018;17(1):140. doi:10.1186/s12943-018-0889-730261900
   PubMed Web of Science ®Google Scholar
• Wu Z, Huang W, Wang X, et al. Circular RNA CEP128 acts as a sponge of miR-145-5p in promoting the bladder cancer progression via regulating SOX11. Mol Med. 2018;24(1):40. doi:10.1186/s10020-018-0039-030134837
   PubMed Web of Science ®Google Scholar
• Tan S, Sun D, Pu W, et al. Circular RNA F-circEA-2a derived from EML4-ALK fusion gene promotes cell migration and invasion in non-small cell lung cancer. Mol Cancer. 2018;17(1):138. doi:10.1186/s12943-018-0887-930236141
   PubMed Web of Science ®Google Scholar
• Ochenduszko S, Puskulluoglu M, Konopka K, et al. Clinical effectiveness and toxicity of second-line irinotecan in advanced gastric and gastroesophageal junction adenocarcinoma: a single-center observational study. Ther Adv Med Oncol. 2017;9(4):223–233. doi:10.1177/175883401668902928491144
   PubMed Web of Science ®Google Scholar
• Benevento I, Bulzonetti N, De Felice F, Musio D, Vergine M, Tombolini V. The role of different adjuvant therapies in locally advanced gastric adenocarcinoma. Oncotarget. 2018;9(74):34022–34029. doi:10.18632/oncotarget.2610630338043
   PubMedGoogle Scholar
• Liu H, Liu Y, Bian Z, et al. Circular RNA YAP1 inhibits the proliferation and invasion of gastric cancer cells by regulating the miR-367-5p/p27 (Kip1) axis. Mol Cancer. 2018;17(1):151. doi:10.1186/s12943-018-0902-130336780
   PubMed Web of Science ®Google Scholar
• Xie F, Li Y, Wang M, et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p/p27 axis. Mol Cancer. 2018;17(1):144. doi:10.1186/s12943-018-0892-z30285878
   PubMed Web of Science ®Google Scholar
• Yan H, Sun BM, Zhang YY, et al. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin. Int J Mol Med. 2018;42(5):2469–2480. doi:10.3892/ijmm.2018.385330226564
   PubMed Web of Science ®Google Scholar
• Chen D, Li SG, Chen JY, Xiao M. MiR-183 maintains canonical Wnt signaling activity and regulates growth and apoptosis in bladder cancer via targeting AXIN2. Eur Rev Med Pharmacol Sci. 2018;22(15):4828–4836. doi:10.26355/eurrev_201808_1561830070321
   PubMed Web of Science ®Google Scholar
• Qiu L, Chang G, Bi Y, Liu X, Chen G. Circular RNA and mRNA profiling reveal competing endogenous RNA networks during avian leukosis virus, subgroup J-induced tumorigenesis in chickens. PLoS One. 2018;13(10):e0204931. doi:10.1371/journal.pone.020493130286182
   PubMed Web of Science ®Google Scholar
• Luo J, Zhang C, Zhan Q, et al. Profiling circRNA and miRNA of radiation-induced esophageal injury in a rat model. Sci Rep. 2018;8(1):14605. doi:10.1038/s41598-018-33038-130279559
   PubMedGoogle Scholar
• Jin C, Bao J, Wang Y, et al. Changes in circRNA expression profiles related to the antagonistic effects of Escherichia coli F17 in lamb spleens. Sci Rep. 2018;8(1):14524. doi:10.1038/s41598-018-31719-530266913
   PubMedGoogle Scholar
• Pan B, Guo J, Liao Q, Zhao Y. beta1 and beta3 integrins in breast, prostate and pancreatic cancer: a novel implication. Oncol Lett. 2018;15(4):5412–5416. doi:10.3892/ol.2018.807629556293
   PubMed Web of Science ®Google Scholar
• Qin Q, Wei F, Zhang J, Li B. miR-134 suppresses the migration and invasion of non‑small cell lung cancer by targeting ITGB1. Oncol Rep. 2017;37(2):823–830. doi:10.3892/or.2017.535028075475
   PubMed Web of Science ®Google Scholar